Table 1.
Type I (anthracycline-like) | Type II (trastuzumab-like) | |
---|---|---|
Cellular mechanism | Cells death | Cells dysfunction |
Dose related | Cumulative | Not-cumulative |
Reversibility | Permanent | Reversible |
Type I (anthracycline-like) | Type II (trastuzumab-like) | |
---|---|---|
Cellular mechanism | Cells death | Cells dysfunction |
Dose related | Cumulative | Not-cumulative |
Reversibility | Permanent | Reversible |